Somatropin(Human Growth Hormone)

Generic Name: Somatropin(Human Growth Hormone)

Brand Names: -

Drug Type: -

Chemical Formula: -

CAS Number: -

Unique Ingredient Identifier: -

Indication: ⑴各种原因引起的生长激素缺乏性侏儒，包括垂体病变及其下丘脑病变所致者；

⑵儿童其他原因引起的矮小症，如特纳综合征，小于胎龄儿等；

⑶成人生长激素缺乏症、儿童特发性矮小等一些国家已批准使用；

⑷烧伤、儿童慢性肾衰等；

⑸用于Prader-Will综合征；【美国FDA已批准重组人生长激素注射液用于Prader-Will综合征；中华医学会儿科学分会内分泌遗传代谢学组《中华儿科杂志》编辑委员会，《基因重组人生长激素儿科临床规范应用的建议》（2013）】
...

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Biosimilars Market Size to Worth USD 114.02 Billion By 2031

The biosimilars market is projected to grow from USD 36.01B in 2024 to USD 114.02B by 2031, at a CAGR of 17.9%. Factors driving growth include rising demand for cost-effective biologics and patent expirations. Key trends include regulatory approvals and new product launches. North America is expected to dominate due to favorable regulations.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy